Pfizer withdraws application for emergency use of its Covid-19 vaccine in India

The US company, which was the first drugmaker to apply for emergency use authorization of its Covid-19 vaccine in India, had a meeting with the country’s drugs regulator on Wednesday and the decision was made after that, the company said.The US company, which was the first drugmaker to apply for emergency use authorization of its Covid-19 vaccine in India, had a meeting with the country’s drugs regulator on Wednesday and the decision was made after that, the company said.